This client alert discusses the Supreme Court's decision that the Federal Circuit must apply the "clear error" standard to factual findings, rather than de novo review, when reviewing patent claim construction proceedings from a District Court. The alert will summarize and analyze the Court's decision in Teva Pharms. USA Inc. v. Sandoz, Inc.